Walking Program With Pedometer on Quality of Life in COPD

Sponsor
Chang Gung University (Other)
Overall Status
Completed
CT.gov ID
NCT05251623
Collaborator
(none)
45
1
2
13
3.5

Study Details

Study Description

Brief Summary

The aim of this study is to investigate the effects of a walking program on exercise capacity and quality of life in patient with COPD. Method: Patients with COPD were randomly assigned to pedometer group (PG) or control group (CON). Subjects in PG walked to target steps daily with pedometer for 6 weeks. Before and after the program, the following measurements were performed: pulmonary function test (PFT), daily steps, Six-Minute Walk Test (6MWT), COPD Assessment Test (CAT), and quality of life questionnaire (SF-12).

Condition or Disease Intervention/Treatment Phase
  • Other: walking program
N/A

Detailed Description

Patients with chronic obstructive pulmonary disease (COPD) are suffered from impaired pulmonary function and dyspnea which result to limited level of physical activity, and impaired quality of life. Exercise and regular physical activity have been proven to break the vicious circle. The aim of this study is to investigate the effects of a walking program on exercise capacity and quality of life in patient with COPD. Method: Patients with COPD were randomly assigned to pedometer group (PG) or control group (CON). Subjects in PG walked to target steps daily with pedometer for 6 weeks. Before and after the program, the pulmonary function was assessed by spiromtery test. The exercise capacity were assessed by six-minute walking test, the physical activity level was assessed by daily steps, The quality of life was assessed by COPD Assessment Test (CAT), and quality of life questionnaire (SF-12).

.

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
The Effect of Walking Program With Pedometer on Quality-of-life Among Chronic Obstructive Pulmonary Disease Patients
Actual Study Start Date :
Mar 1, 2018
Actual Primary Completion Date :
Mar 31, 2018
Actual Study Completion Date :
Mar 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: pedometer

walking with pedometer

Other: walking program
Subjects in PG walked to target steps daily with pedometer for 6 weeks

No Intervention: control

no intervention

Outcome Measures

Primary Outcome Measures

  1. tidal volume [week 0]

    the amount of air that moves in or out of the lungs with each respiratory cycle. It is measured by spirometers.

  2. tidal volume [week 7]

    the amount of air that moves in or out of the lungs with each respiratory cycle. It is measured by spirometers.

  3. Short-form 12 questionnaire (SF-12) [week 0]

    The SF-12 is a quality of life questionnaire. The scores range from 0 (worst conceivable QOL) to 100 (best conceivable QOL)

  4. Short-form 12 questionnaire (SF-12) [week 7]

    The SF-12 is a quality of life questionnaire. The scores range from 0 (worst conceivable QOL) to 100 (best conceivable QOL)

  5. 6 minute walking test [week 0]

    walking distance

  6. 6 minute walking test [week 7]

    walking distance

  7. daily steps [week0]

    the number of total walking steps per day which is measured by pedometer.

  8. daily steps [week 7]

    the number of total walking steps per day which is measured by pedometer.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. diagnosed with COPD

  2. in a medically stable condition

  3. able to walk unassisted

  4. ≥ 40 years of age

Exclusion Criteria:
  1. oxygen therapy,

  2. hemodynamic instability,

  3. signs/symptoms of acute infection

  4. severe neurological, musculoskeletal, or cardiovascular conditions that affect walking

Contacts and Locations

Locations

Site City State Country Postal Code
1 Taoyuan General Hospital Taoyuan Taiwan 333

Sponsors and Collaborators

  • Chang Gung University

Investigators

  • Principal Investigator: Yen-Huey Chen, PhD, Chang Gung University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chen Yen-Huey, assist professor, Chang Gung University
ClinicalTrials.gov Identifier:
NCT05251623
Other Study ID Numbers:
  • TYGH106081
First Posted:
Feb 23, 2022
Last Update Posted:
Feb 23, 2022
Last Verified:
Feb 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Chen Yen-Huey, assist professor, Chang Gung University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 23, 2022